[Models of urinary infection].
D000818:Animals; D001424:Bacterial Infections; D001437:Bacteriuria / Q000382:microbiology; D002228:Carbenicillin / Q000627:therapeutic use; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D004926:Escherichia coli / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000382:microbiology; D005839:Gentamicins / Q000627:therapeutic use; D007612:Kanamycin / Q000627:therapeutic use; D007668:Kidney / Q000382:microbiology; D051379:Mice; D009582:Nitrofurantoin / Q000627:therapeutic use; D011549:Pseudomonas / Q000302:isolation & purification; D011552:Pseudomonas Infections / Q000382:microbiology; D011704:Pyelonephritis / Q000382:microbiology; D011817:Rabbits; D051381:Rats; D013411:Sulfadiazine / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy
D005839:Gentamicins; D013411:Sulfadiazine; D007612:Kanamycin; D009582:Nitrofurantoin; D014295:Trimethoprim; D002228:Carbenicillin; D013420:Sulfamethoxazole
Modellinfektionen der Harnwege